This dysfunctional glycolysis profile shares similarities with findings from proteomic studies of PBMCs from critically ill COVID-19 patients (28), transcriptomic/metabolic profiling of CD14+ monocytes from patients with moderate COVID-19 (38), and single-cell RNA sequencing in monocytes and macrophages from severe patients with COVID-19-associated pulmonary aspergillosis (39). The gene discussed is CD14; the disease is COVID-19.